Leading-edge cancer therapy. To people who are considering cancer immunotherapy

New City Osaki Clinic homepage  >  Leading-edge cancer therapy  >  Patent

Granted patents

Method for activation of NK cells, method for proliferation of NK cells and method for production of cells using this method for activation of NK cells, and monocytes including NK cells

Patent number: 5459129
Title of invention: “Method for activation of NK cells, method for proliferation of NK cells and method for production of cells using this method for activation of NK cells, and monocytes including NK cells”
Inventor: Cellex Inc.
Application number: 2010-164904
Registration date: January 24, 2014



Agent for prevention of cancer development, agent for improvement of antibody productivity and agent for treatment of hepatitis

Patent number: 5016732
Title of invention: “Agent for prevention of cancer development, agent for improvement of antibody productivity and agent for treatment of hepatitis”
Inventors: Cellex Inc.
Application number: 2011-537767
Registration date: June 15, 2012



Method for activation of NK cells, method for proliferation of NK cells and method for production of cells using this method for activation of NK cells, and monocytes including NK cells

Patent number: 4645312
Title of invention: “Method for activation of NK cells, method for proliferation of NK cells and method for production of cells using this method for activation of NK cells, and monocytes including NK cells”
Inventor: Cellex Inc.
Application number: 2005-171737
Registration date: December 17, 2010



Immunotherapy for Pancreatic Cancer

“Osaki method” of highly active NK (natural killer) cell therapy obtain US Patent.
Patent number: US 8,613,916 B2
Title of invention: “Immunotherapy for Pancreatic Cancer”
Inventor: Cellex Inc.
Application number: 13/377,839
Registration date: December 24, 2013
US Patent 8,613,916 (United States Patent and Trademark Office)

 

Cancer immunotherapy

Immune system | Cancer immunotherapy | Highly active NK cell therapy | Problems of highly active NK cells | Characteristics of highly active NK cells | “immunity-enhancing effect” of highly active NK cells | Recommendation of highly active NK cell therapy